Wolverine combines two of the most powerful regenerative peptides into a single vial — TB-500 (Thymosin Beta-4) and BPC-157. Working synergistically, they accelerate healing of muscles, tendons, ligaments and joints, reduce inflammation, and promote lasting tissue repair. Here is what the science shows — and where to buy TB-500 and BPC-157 in South Africa.
The Wolverine healing peptide combines two of the most extensively researched regenerative peptides in a single 20mg vial: 10mg of TB-500 (the synthetic, bioavailable form of Thymosin Beta-4) and 10mg of BPC-157 (Body Protection Compound-157). Each peptide targets distinct but complementary healing mechanisms — together they produce a synergistic effect greater than either compound alone.
TB-500 works primarily at a systemic level, promoting cell migration, angiogenesis, and flexibility restoration in damaged connective tissue throughout the body. BPC-157 exerts more localised effects, activating growth factors at injury sites, protecting the gastrointestinal system, and accelerating tendon and ligament repair. The combination is particularly effective for overuse injuries, post-surgical recovery, and chronic musculoskeletal conditions.
Thymosin Beta-4 is a naturally occurring 43-amino acid peptide found in virtually all human and animal cells. It is a major actin-sequestering protein — meaning it plays a fundamental role in cytoskeletal organisation, cell migration, and wound healing. TB-500 is the truncated, synthetic form designed for subcutaneous administration.
TB-500 was shown to activate integrin-linked kinase (ILK), promote cardiac cell migration and survival, and significantly improve cardiac repair following myocardial infarction in animal models — one of the most cited findings in the Thymosin Beta-4 literature.
Read on Nature →This landmark review established Thymosin Beta-4 as a moonlighting protein — a molecule with primary intracellular functions (actin sequestration) that is also secreted to exert powerful extracellular repair effects, including wound healing and anti-inflammatory activity.
Topical and systemic Thymosin Beta-4 significantly accelerated wound closure and re-epithelialisation in animal models, with treated wounds showing superior collagen deposition and vascularisation compared to untreated controls.
A recent scoping review maps the preclinical and human evidence for TB-500 across ocular, wound/skin, and musculoskeletal repair settings, confirming broad interest in its regenerative pathways while noting most direct evidence remains preclinical.
Read on MDPI →A comprehensive review of Thymosin Beta-4 biology summarising its role in cell migration, angiogenesis, and anti-inflammatory signalling, and its investigated applications across cardiac, dermal, and corneal repair.
Read on PubMed →BPC-157 significantly promoted tendon outgrowth, cell survival, and cell migration via the FAK-paxillin pathway — the complementary local mechanism that pairs with TB-500's systemic effects in the Wolverine blend.
Read on PubMed →Wolverine 20mg (TB-500 + BPC-157) currently on special at R950 (normal R1,100). 99% purity, COA available, bacwater included. Fast nationwide delivery from Helix Collective SA.